Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia
This study is ongoing, but not recruiting participants.
First Received: August 12, 2008   No Changes Posted
Sponsored by: Imperial College London
Information provided by: Imperial College London
ClinicalTrials.gov Identifier: NCT00733655
  Purpose

Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels. We propose to obtain small skin samples from patients with HHT in order to analyze the samples using histological methods, and study the properties of vascular endothelial cells derived from patients. We hypothesize that these cells will show altered growth, migration, and protein synthetic differences when compared to normal endothelial cells, which may be confirmed in single time point analyses in histological samples. We anticipate that that these findings may help to explain aspects of the HHT disease phenotype.


Condition
Telangiectasia, Hereditary Hemorrhagic

Genetics Home Reference related topics: hemophilia hereditary hemorrhagic telangiectasia
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Hereditary Haemorrhagic Telangiectasia

Exclusion Criteria:

  • Unable to provide informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00733655

Locations
United Kingdom
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Claire L Shovlin Imperial College London
  More Information

No publications provided

Study ID Numbers: IC/CLS5
Study First Received: August 12, 2008
Last Updated: August 12, 2008
ClinicalTrials.gov Identifier: NCT00733655     History of Changes
Health Authority: United Kingdom: Research Ethics Committee

Study placed in the following topic categories:
Hemorrhagic Disorders
Cardiovascular Abnormalities
Hematologic Diseases
Telangiectasia, Hereditary Hemorrhagic
Blood Coagulation Disorders
Vascular Malformations
Telangiectasis
Vascular Diseases
Hereditary Hemorrhagic Telangiectasia
Congenital Abnormalities
Hemostatic Disorders

Additional relevant MeSH terms:
Hemorrhagic Disorders
Cardiovascular Abnormalities
Hematologic Diseases
Telangiectasia, Hereditary Hemorrhagic
Vascular Malformations
Telangiectasis
Vascular Diseases
Cardiovascular Diseases
Congenital Abnormalities
Hemostatic Disorders

ClinicalTrials.gov processed this record on May 07, 2009